Merck to present new research data across its HIV prevention and treatment pipeline at IAS 2025
Additional data will be presented on a once-weekly oral combination of islatravir and ulonivirine (ISL/ULO) for HIV-1 treatment
Additional data will be presented on a once-weekly oral combination of islatravir and ulonivirine (ISL/ULO) for HIV-1 treatment
Prof. Götz is Director of the Institute of Stem Cell Research at Helmholtz Center Munich and Chair of Physiological Genomics at Ludwig-Maximilians-Universität, Munich
The company showcased three core programs developed through this platform
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
Innovative agents highlight growth of targeted protein degradation platform and BMS' leadership in innovative cancer therapies
Launches FSSAI’s inclusive campaign to stop obesity with multilingual, sign language outreach and multi-platform media engagement under Eat Right India programme
Merck KGaA, Darmstadt, Germany announced the presentation of new oncology data across more than 12 tumor types at ASCO 2025
Standalone profit from operations for the quarter were Rs. 162 crores
Subscribe To Our Newsletter & Stay Updated